Bumetanide appears to be effective in treating 30 to 40 percent of children with autism
You may recall our clinical trials and experimental studies based on my concept of Neuroarcheology, which posited that pathological events in utero result in misplaced and poorly connected neurons that generate immature neural activity—which is ultimately the true direct cause of autism. These must therefore be blocked. Using bumetanide—an agent that blocks this hyperactivity and … Read more
